| Dr Howard Douglas Stirne, MD | |
|
601 S 8th St, Griffin, GA 30224-4213 | |
| (770) 228-2721 | |
| Not Available |
| Full Name | Dr Howard Douglas Stirne |
|---|---|
| Gender | Male |
| Speciality | Emergency Medicine |
| Location | 601 S 8th St, Griffin, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1942247929 | NPI | - | NPPES |
| 000291992K | Medicaid | GA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207P00000X | Emergency Medicine | 025050 (Georgia) | Primary |
| Entity Name | Southland Dodge Emergency Medical Services, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1851958607 PECOS PAC ID: 8224360805 Enrollment ID: O20191031001338 |
News Archive
An article published in Hemodialysis International discusses the role of oxidative stress (OS) in dialysis patients, an imbalance which can result in long-term health problems. Potential therapeutic options to restore balance in patients are also reviewed.
Silence Therapeutics plc announces that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in March 2008, the companies are leveraging a number of Silence's proprietary lipid delivery and targeting technologies to develop new and enhanced delivery approaches for RNA interference (RNAi) therapeutics.
Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, were developed at an unprecedented pace. To date, more than 1 billion vaccine doses have been administered worldwide, many of which messenger RNA (mRNA) based.
XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.
Blood pressure readings taken at home with approved devices can be a useful addition to blood pressure management, and may even predict cardiovascular disease (CVD) risk better than readings from the doctor's office alone, according to a scientific statement issued today by the American Heart Association.
› Verified 2 days ago
| Entity Name | Southland Dodge Hospitalist Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1346894334 PECOS PAC ID: 7113259664 Enrollment ID: O20191101001455 |
News Archive
An article published in Hemodialysis International discusses the role of oxidative stress (OS) in dialysis patients, an imbalance which can result in long-term health problems. Potential therapeutic options to restore balance in patients are also reviewed.
Silence Therapeutics plc announces that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in March 2008, the companies are leveraging a number of Silence's proprietary lipid delivery and targeting technologies to develop new and enhanced delivery approaches for RNA interference (RNAi) therapeutics.
Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, were developed at an unprecedented pace. To date, more than 1 billion vaccine doses have been administered worldwide, many of which messenger RNA (mRNA) based.
XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.
Blood pressure readings taken at home with approved devices can be a useful addition to blood pressure management, and may even predict cardiovascular disease (CVD) risk better than readings from the doctor's office alone, according to a scientific statement issued today by the American Heart Association.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Howard Douglas Stirne, MD 14050 Nw 14th St, Suite 190, Sunrise, FL 33323-2865 Ph: (800) 424-3672 | Dr Howard Douglas Stirne, MD 601 S 8th St, Griffin, GA 30224-4213 Ph: (770) 228-2721 |
News Archive
An article published in Hemodialysis International discusses the role of oxidative stress (OS) in dialysis patients, an imbalance which can result in long-term health problems. Potential therapeutic options to restore balance in patients are also reviewed.
Silence Therapeutics plc announces that the Company and AstraZeneca have agreed to a one-year extension of their ongoing small interfering RNA (siRNA) delivery collaboration. Under this collaboration, which was originally entered into in March 2008, the companies are leveraging a number of Silence's proprietary lipid delivery and targeting technologies to develop new and enhanced delivery approaches for RNA interference (RNAi) therapeutics.
Vaccines against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the causative agent of COVID-19, were developed at an unprecedented pace. To date, more than 1 billion vaccine doses have been administered worldwide, many of which messenger RNA (mRNA) based.
XBiotech, a privately held biotechnology company, announced today that it is entering the biosimilar business. The Company is launching its biosimilar business with development of two of the world's leading therapeutic antibodies, one an oncology and the other an anti-inflammatory product.
Blood pressure readings taken at home with approved devices can be a useful addition to blood pressure management, and may even predict cardiovascular disease (CVD) risk better than readings from the doctor's office alone, according to a scientific statement issued today by the American Heart Association.
› Verified 2 days ago
Dr. Jestina S Mason, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 | |
Dr. Dwayne L Watkins, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 327 S 9th St, Griffin, GA 30224 Phone: 770-233-9293 Fax: 770-233-0998 | |
Dr. Ike A Nwaobi, M.D. Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 704-676-3147 | |
Dr. Kamlesh Patel, MD Emergency Medicine Medicare: Accepting Medicare Assignments Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 | |
Nneka Clara Azih, Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 | |
Dr. Jehangir Tanveer Pirzada, D.O. Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 248-709-6524 | |
Dr. Henry Michael Webb, MD Emergency Medicine Medicare: Medicare Enrolled Practice Location: 601 S 8th St, Griffin, GA 30224 Phone: 770-228-2721 |